SLC6A6 Knockout HCT 116 Cell Line
Cat.No.:
EDC08393
Species:
Human
Cell Name:
HCT 116
Gene:
SLC6A6
Gene ID:
6533
Size:
1×10⁶cells
SLC6A6 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08393 |
|---|---|
| Product Name | SLC6A6 Knockout HCT 116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC6A6 |
| NCBI Gene ID | |
| Gene Synonyms | HTRDC|TAUT |
| Summary |
This gene encodes a multi-pass membrane protein that is a member of a family of sodium and chloride-ion dependent transporters. The encoded protein transports taurine and beta-alanine. There is a pseudogene for this gene on chromosome 21. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
|
| Associated Diseases | Colorectal Carcinoma |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC6A6 function, SLC6A6 Knockout HCT 116 Cell Line or SLC6A6 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC6A6 (TauT)'s role in taurine transport or its emerging functions in osmoregulation and antioxidant homeostasis. The Knockout line is the standard tool for asking whether SLC6A6 is required for taurine uptake — TauT is the principal sodium-dependent taurine transporter expressed in many tissues including intestinal epithelium. Overexpression is useful for transport kinetics studies and for assessing inhibitor specificity.
For taurine biology research, the EDITGENE SLC6A6 Knockout in HCT 116 is relevant for studying intestinal taurine handling and the emerging role of taurine in colorectal cancer biology. TauT mutations cause autosomal recessive retinal degeneration — disease variant rescue enables genotype-function studies. Rescue with wild-type or transport-deficient TauT is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• Taurine uptake: ³H-taurine or LC-MS-based intracellular taurine measurement to quantify TauT activity in the absence of SLC6A6.
• Osmoregulation studies: cellular response to hypertonic stress in the presence and absence of TauT-mediated taurine uptake.
• Antioxidant biology: glutathione levels and oxidative stress response analysis given taurine's reported antioxidant roles.
• Drug-substrate interaction studies: testing taurine-conjugate uptake or TauT inhibitor specificity.
EDITGENE recommends this model for researchers investigating taurine biology, osmoregulation, and TauT-mediated transport in intestinal/cancer contexts.
Is this SLC6A6 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. TauT rescue experiments require attention to membrane topology and substrate recognition:
• Construct design: use a codon-modified SLC6A6 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane SLC6 family architecture must be preserved.
• Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing transport from non-transport functions.
• Disease mutation rescue: retinal degeneration-associated SLC6A6 variants enable disease genotype-function correlation studies.
• Functional readout: rescue should restore ³H-taurine uptake activity and downstream phenotypes related to taurine-dependent processes.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.